A look at the evidence for topical lidocaine's effectiveness in managing pain.

On the shelf: a 4% lidocaine cream. In the literature: a 5% patch, first-line for postherpetic neuralgia (2004 review); lidocaine over placebo in all but one study (2014 Cochrane); a weak second-line nod for 5% plasters (2025 meta-analysis).
The cream is a lower concentration than the patches studied. Fair promise: possible localized relief, minimal systemic absorption — expectations tempered.
Several studies have examined the effectiveness of lidocaine in various forms for pain relief. In a 2004 review, a 5% lidocaine patch was found to provide relief from postherpetic neuralgia (PHN) pain and tactile allodynia with minimal risk of systemic side effects. It was recommended as a first-line therapy for PHN.
A 2014 Cochrane review found that topical lidocaine was better than placebo for some measure of pain relief in all but one study. Clinical experience also supports its efficacy in some patients with neuropathic pain.
However, a 2025 meta-analysis gave only a weak recommendation for lidocaine 5% plasters as a second-line treatment for neuropathic pain. And a 2017 Cochrane overview found limited evidence for topical analgesics in chronic musculoskeletal conditions over 6-12 weeks.
While the evidence suggests lidocaine can provide some pain relief, especially for neuropathic pain like PHN, the strength of the recommendations varies. The 4% lidocaine cream in Aspercreme is a lower concentration than the 5% patches studied. So while it may offer localized pain relief with minimal systemic effects, expectations should be tempered based on the mixed and limited evidence for topical analgesics overall. Educational, not medical advice.
Aspercreme 4% lidocaine cream may provide some localized pain relief, especially for neuropathic pain, but the evidence is mixed and expectations should be realistic based on the lower concentration and limited data on topical analgesics.
What that grade means: Several human studies point the same way, but with limits — size, duration, funding, or mixed results.
Typical listed price $13.00 — check the live price before buying.
5 peer-reviewed sources, published 2004–2025, across 4 journals. Every citation links to its PubMed record.
Each links to its Magellan monograph — what it is, what it does, and the studies behind it.
A look at the evidence for Biofreeze Menthol Pain Relief Gel’s effects on pain and its implications for…
A look at whether topical capsaicin cream like Capzasin-HP actually relieves pain, based on scientific…
Evidence suggests the Salonpas Pain Relieving Patch can provide temporary relief for minor musculoskeletal…
Prefer the interactive version? Open this article inside the Magellan app →